Your session is about to expire
← Back to Search
Community Health Program for COVID-19 (WEAVE Trial)
N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months after 2nd stage randomization
Awards & highlights
WEAVE Trial Summary
This trial will optimize, implement & test a multi-component health program to measure impact on implementation & outcomes. A participatory approach & hybrid randomized trial design will be used.
Who is the study for?
This trial is for adults over 18 who are patients at specific San Ysidro Health clinics in Escondido, El Cajon, or Community Heights and speak Spanish, Arabic, or Vietnamese. It's not open to those who can't consent, aren't patients at these clinics, don't speak the required languages, or are under 18.Check my eligibility
What is being tested?
The study tests a health program aimed at increasing vaccination and preventive care through cultural engagement (Cultural Weavers), mobile health outreach with culturally relevant messages (mHealth), and improved care coordination. The effectiveness of these strategies will be evaluated using a participatory approach.See study design
What are the potential side effects?
Since this trial focuses on community-driven approaches rather than medical treatments or drugs, there are no direct side effects like you'd expect from medication. However, participants may experience issues related to privacy concerns with mHealth tools.
WEAVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
WEAVE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 months after 2nd stage randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months after 2nd stage randomization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
COVID-19 vaccination rate
Secondary outcome measures
Preventive services engagement rate
WEAVE Trial Design
5Treatment groups
Experimental Treatment
Active Control
Group I: Stage 2 mHealth Outreach + Care CoordinationExperimental Treatment2 Interventions
Group II: Stage 2 mHealth OutreachExperimental Treatment1 Intervention
Group III: Stage 1 mHealth OutreachExperimental Treatment1 Intervention
Group IV: Stage 1 Standard of CareActive Control1 Intervention
Group V: Stage 2 Standard of CareActive Control1 Intervention
Find a Location
Who is running the clinical trial?
San Ysidro Health CenterOTHER
6 Previous Clinical Trials
9,277 Total Patients Enrolled
2 Trials studying COVID-19
8,554 Patients Enrolled for COVID-19
University of California, San DiegoLead Sponsor
1,130 Previous Clinical Trials
1,552,556 Total Patients Enrolled
13 Trials studying COVID-19
17,269 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak Spanish, Arabic, or Vietnamese.I am unable to understand or sign the consent form.I am under 18 years old.I am 18 years old or older.I speak Spanish, Arabic, or Vietnamese.
Research Study Groups:
This trial has the following groups:- Group 1: Stage 2 mHealth Outreach + Care Coordination
- Group 2: Stage 1 mHealth Outreach
- Group 3: Stage 2 mHealth Outreach
- Group 4: Stage 1 Standard of Care
- Group 5: Stage 2 Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger